MENU

IRD Opus Genetics Inc Forecast, Technical & Fundamental Analysis

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders... Show more

IRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
IRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DRLIX9.32N/A
N/A
BNY Mellon Developed Markets RE Scs - I
VCGEX10.26N/A
N/A
VALIC Company I Emerg Economies
FBBAX26.49N/A
N/A
Fundamental Family Office Allocation A
VEVIX49.90N/A
N/A
Victory Sycamore Established Value I
BSCUX29.71N/A
N/A
Baron Small Cap R6

IRD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IRD has been loosely correlated with ROIV. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IRD jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRD
1D Price
Change %
IRD100%
-0.25%
ROIV - IRD
39%
Loosely correlated
-0.64%
IMUX - IRD
36%
Loosely correlated
+4.79%
ARRY - IRD
35%
Loosely correlated
+6.75%
MGX - IRD
34%
Loosely correlated
-0.83%
BEAM - IRD
32%
Poorly correlated
+4.07%
More
Opus Genetics (IRD) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com